Asarfi Hospital Ltd
Asarfi Hospital Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Revenue projection for FY26 is Rs.160 crores with a PAT margin of 13% to 15%. Revenue Growth: Projected to increase from Rs.160 crores in FY26 to Rs.200+ crores by FY27.
From Asarfi Hospital Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Revenue projection for FY26 is Rs.160 crores with a PAT margin of 13% to 15%.
- For FY27, expected revenue is around Rs.200 crores with similar or slightly improved margins.
- Target to increase total bed capacity from current 330 beds to 500 beds by FY27.
- Plans to expand cancer hospital beds from 65 to 150, leveraging existing infrastructure, requiring minimal CAPEX.
- Focus on ramping up cancer operations to improve occupancy and revenue.
- Brownfield projects and possible acquisitions (including a 70-bed promoter hospital) to support bed and revenue growth.
2 more points from Asarfi Hospital Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Asarfi Hospital Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Expansion of cancer hospital from 65 to 150 beds; minimal CAPEX as infrastructure is mostly in place (Page 4).
- Brownfield projects for bed expansion, focusing on reduced CAPEX and faster turnaround (Page 15).
- CAPEX for 200-bed expansion estimated under Rs.10 crores, funded through internal accruals, to be completed before FY2027 (Page 13).
- Construction of additional 65 beds in existing unit mostly done; equipment installation needed (~Rs.3 crores) (Page 7).
- Rs.4 crores invested in hostel infrastructure to support manpower and paramedical/ nursing education expansion (Page 6).
- Establishment of bone marrow transplant unit planned for next year; permission applied and facility expected operational by next year (Pages 5 and 12).
2 more points from Asarfi Hospital Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Asarfi Hospital Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Asarfi Hospital Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Asarfi Hospital Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹45 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Asarfi Hospital's management said in earlier quarters
Others in Healthcare Services this season
- Maitreya Medica. (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medica.'s Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hosp (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Arthneeti Pro · Annual
Asarfi Hospital Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Asarfi Hospital Ltd Q2 FY26 results?
Revenue projection for FY26 is Rs.160 crores with a PAT margin of 13% to 15%. Revenue Growth: Projected to increase from Rs.160 crores in FY26 to Rs.200+ crores by FY27.
What is Asarfi Hospital Ltd share price analysis?
Asarfi Hospital Ltd currently shows a neutral. The stock trades at a P/E of 25.0 with a market cap of ₹454 Cr. Investors should review the full earnings analysis for detailed insights.
Is Asarfi Hospital Ltd planning capital expenditure?
Expansion of cancer hospital from 65 to 150 beds; minimal CAPEX as infrastructure is mostly in place (Page 4).
Keep Asarfi Hospital Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.